Newsroom
Category: Institute for Healthy Aging
November 16, 2016 • Center for Alzheimer’s and Neurodegenerative Disease Research, Institute for Healthy Aging
By Jan Jarvis Can an anti-inflammatory drug commonly used for headaches possibly treat or prevent Alzheimer’s disease? The answer might depend on who’s taking the drug, according to Sid O’Bryant, PhD, Professor in the Center for Alzheimer’s and Neurodegenerative Disease Research at UNT Health Science Center. There’s substantial evidence that non-steroidal anti-inflammatory drugs (NSAID)…
November 8, 2016 • Center for Neuroscience Discovery, Health Institutes, Institute for Healthy Aging
By Jan Jarvis An eye drop that could prevent blindness caused by glaucoma is one step closer to becoming a reality. A novel pharmacological intervention to control retinal ganglion cell death caused by glaucoma is in preclinical development, said Katalin Prokai-Tatrai, PhD, Associate Professor in the Center for Neuroscience Discovery and the Department of Pharmaceutical Sciences…
October 7, 2016 • Center for Geriatrics, Geriatrics, Health Institutes, Institute for Healthy Aging
By Jan Jarvis At a glance The trend Americans are living longer. The average life expectancy in the United States is now 78. The need By 2030, about 30,000 geriatricians will be needed to care for 21 million older Americans. It is projected that 30 percent of the 65-plus population will need to be…
September 26, 2016 • Health Institutes, Institute for Healthy Aging
By Jan Jarvis Today there are more than 75,000 centenarians living in the United States, a number that is expected to grow to 600,000 by mid-century. Why some people reach that milestone while others are burdened with diseases is at the crux of the International Conference on Aging and Disease, beginning Friday at the Stanford…
September 16, 2016 • Center for Neuroscience Discovery, Institute for Healthy Aging
By Jan Jarvis When someone has an ischemic stroke - meaning a brain blood vessel is blocked - every minute counts in the race to reduce damage. But getting the clot-busting drug tPA in time is challenging for the 800,000 Americans who experience a stroke each year, said John A. Schetz, PhD, Professor of…
May 10, 2016 • Health Institutes, Institute for Healthy Aging, Research
By Jan Jarvis Photo credit: Carlos Rene Perez/Weill Cornell Medicine Parkinson’s disease is slow but relentless, and progresses over some 20 years. It takes the body, but leaves the mind intact until the late stages, said Dr. Gregory Petsko, a renowned scientist who will speak at the Neurobiology of Aging Trainee Symposium, hosted by…
Social media